Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why outsourcing innovation can be as risky, and costly, as internal discovery.

Argent BioPharma and AusCann Group join forces through a new strategic agreement to advance cannabinoid-based pharmaceutical development. ... Read More The post Argent and AusCann partner to ...

The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...

A report claimed that employees in the age group of 50-55 years working in Dr Reddy’s research and development (R&D) division ...

Dr. Reddy's Laboratories has refuted media reports alleging a 25% reduction in workforce costs. The Hyderabad-based pharmaceutical giant dismissed cla ...

Pharma giant Dr Reddy’s Laboratories is reportedly cutting workforce-related costs by nearly 25%, signaling one of the most ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...